September 16, 2026 |

The event speaker panel, from left to right: Brian Kiefel, Ireland Site Leader & CTO, Honeywell; Christopher Chung, Chief Executive Officer, EDPNC; Tom Scrivener, Group COO, Bank of America; Ambassador of Ireland to the United States Geraldine Byrne Nason; Ger Rabbitte, CEO, Uniphar; Kevin Sherry, Executive Director, Enterprise Ireland; Deirdre MacCarthy, Chief Legal Officer, Wayflyer; and Seamus Egan, Commercial Director, Uniphar.
Industry representatives, economic development leaders and senior executives from Uniphar plc gathered at the company’s new 330,000 sq. ft. Greenogue G2 facility in Dublin last week to welcome North Carolina Governor Josh Stein during his visit to Ireland.
The Governor’s visit reflects the growing economic relationship between North Carolina and Ireland with Irish companies employing around 7,000 people across the state, while North Carolina exported nearly $890 million in goods to Ireland last year. Uniphar’s expanding investment in North Carolina includes its 65,000 sq. ft. pharmaceutical and life sciences logistics hub in Raleigh, supporting the movement of healthcare products and services throughout the United States (US) and worldwide.

Josh Stein, North Carolina Governor meets Ger Rabbitte, CEO, Uniphar; Kevin Sherry, Executive Director, Enterprise Ireland and Brian O’Shaughnessy, CCO, Uniphar.
Welcoming Governor Stein, Ger Rabbette, Chief Executive Officer of Uniphar plc, highlighted the strategic importance of the facility as well as the company’s growing presence in the US.
“Greenogue is one of the most sophisticated pharmaceutical distribution facilities in Europe, but it also represents a broader vision for building a more connected global healthcare infrastructure across Ireland, the UK, Europe and the United States. North Carolina was a natural choice for our US East Coast hub, providing access to one of the country’s most dynamic life sciences ecosystems and enabling us to support customers across the region. We are proud to contribute to the strong and growing economic relationship between Ireland and the United States, and particularly the partnership between Ireland and North Carolina.”
North Carolina is recognized as one of the leading life sciences centers in the United States, with a thriving pharmaceutical, biotechnology and medical technology sector. Uniphar’s 65,000 sq. ft. Raleigh distribution hub, located in North Carolina’s Research Triangle region, forms a key component of its global logistics network, connecting North American customers with the company’s wider operations across Europe, Asia-Pacific and the Middle East.
The Greenogue facility is Uniphar’s new 330,000 sq. ft. LEED Gold-certified distribution hub and one of the most advanced pharmaceutical logistics facilities in Europe. Featuring state-of-the-art automation and advanced storage and picking technologies, it forms part of Uniphar’s wider international infrastructure program to strengthen healthcare supply chains through a network of strategic distribution centers across Ireland, the UK, Europe and the United States.
From these facilities, Uniphar supports more than 200 multinational pharmaceutical and medical technology manufacturers, delivering healthcare products to over 160 countries worldwide.
Governor Stein praised both the scale of Uniphar’s investment in Ireland and the company’s commitment to North Carolina:
“Uniphar’s investment in Raleigh reflects the strong and growing partnership between North Carolina and Ireland. Its East Coast hub has further strengthened our state’s world-class life sciences sector and created new opportunities for trade and collaboration. Uniphar is one of nearly 50 Irish companies employing more than 7,000 North Carolinians, making Ireland an important part of North Carolina’s success story.”
ENDS
This content was provided by Uniphar
Latest Content from Uniphar
Cell and gene therapies (CGT) provide transformative treatment that can treat conditions that were previously considered untreatable. As described in the previous article in this series, most CGTs target patients…
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia,…
Dublin, Ireland 16th July 2025 – Leading global healthcare services provider, Uniphar, has launched Uniphar | Global Sourcing, a new identity for its On Demand business that strengthens its position…
[Dublin, April 17th 2025] Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy (CGT) project. The milestone reinforces Uniphar’s…
[Dublin, 05 February 2025] Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new, state-of-the-art facilities, strategically positioned across key global…
Isaac Batley, an experienced CEO with 35 years’ experience within healthcare and pharmaceutical communications, joins Uniphar to spearhead its medical communications division.
Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 57 years in the industry delivering specialist services to more than 200 international clients across 180 countries.
